

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.76500318 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 6.22281537 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 6.22281537 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.22281537 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.22281537 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.22281537 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.22281537 |
| 8 | * neutrophil activation involved in immune response (GO:0002283) | 5.70525293 |
| 9 | respiratory burst (GO:0045730) | 5.52164475 |
| 10 | response to peptidoglycan (GO:0032494) | 5.37549755 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.08047305 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.08047305 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83764907 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.82573897 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.59787503 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.49582267 |
| 17 | microglial cell activation (GO:0001774) | 4.48543362 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.44321227 |
| 19 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.39657989 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.36205389 |
| 21 | detection of other organism (GO:0098543) | 4.34852194 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25219856 |
| 23 | superoxide anion generation (GO:0042554) | 4.24971661 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.23193495 |
| 25 | * granulocyte activation (GO:0036230) | 4.21504178 |
| 26 | * macrophage activation involved in immune response (GO:0002281) | 4.20299440 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.19627152 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 4.19627152 |
| 29 | reactive oxygen species biosynthetic process (GO:1903409) | 4.19292662 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17702966 |
| 31 | response to host immune response (GO:0052572) | 4.17702966 |
| 32 | positive regulation of mast cell activation (GO:0033005) | 4.16948491 |
| 33 | detection of bacterium (GO:0016045) | 4.16656950 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.14003232 |
| 35 | eosinophil chemotaxis (GO:0048245) | 4.11529381 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 4.11517148 |
| 37 | * neutrophil activation (GO:0042119) | 4.01595175 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 4.00399222 |
| 39 | * myeloid cell activation involved in immune response (GO:0002275) | 3.95249670 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95245249 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.91319386 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.87216674 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.85496386 |
| 44 | eosinophil migration (GO:0072677) | 3.80298776 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77201138 |
| 46 | regulation of mast cell activation (GO:0033003) | 3.76793961 |
| 47 | cellular extravasation (GO:0045123) | 3.76214048 |
| 48 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.76140232 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.73630328 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.69473169 |
| 51 | response to host (GO:0075136) | 3.69473169 |
| 52 | response to host defenses (GO:0052200) | 3.69473169 |
| 53 | leukocyte aggregation (GO:0070486) | 3.61707747 |
| 54 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59890057 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 3.54123720 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 3.52768526 |
| 57 | leukocyte mediated cytotoxicity (GO:0001909) | 3.48954013 |
| 58 | B cell mediated immunity (GO:0019724) | 3.48799476 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.47289813 |
| 60 | neutrophil mediated immunity (GO:0002446) | 3.44301256 |
| 61 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.43996093 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.41815676 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41196487 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.39923319 |
| 65 | type I interferon signaling pathway (GO:0060337) | 3.39923319 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 3.39683756 |
| 67 | regulation of leukocyte degranulation (GO:0043300) | 3.38748429 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37021227 |
| 69 | * macrophage activation (GO:0042116) | 3.36963045 |
| 70 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.36000344 |
| 71 | monocyte chemotaxis (GO:0002548) | 3.35658024 |
| 72 | response to type I interferon (GO:0034340) | 3.35240777 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 3.33907836 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.33002036 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32983798 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 3.28093834 |
| 77 | defense response to protozoan (GO:0042832) | 3.28012042 |
| 78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.27083268 |
| 79 | pinocytosis (GO:0006907) | 3.26590931 |
| 80 | cellular response to zinc ion (GO:0071294) | 3.25377956 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 3.24181775 |
| 82 | myeloid dendritic cell differentiation (GO:0043011) | 3.24121045 |
| 83 | germinal center formation (GO:0002467) | 3.21245776 |
| 84 | neutrophil chemotaxis (GO:0030593) | 3.21161405 |
| 85 | mast cell activation (GO:0045576) | 3.20188974 |
| 86 | phagosome maturation (GO:0090382) | 3.19653882 |
| 87 | negative regulation of mast cell activation (GO:0033004) | 3.19086851 |
| 88 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.18493514 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17606164 |
| 90 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.17270839 |
| 91 | positive regulation of interferon-beta production (GO:0032728) | 3.17237258 |
| 92 | * myeloid leukocyte activation (GO:0002274) | 3.16941700 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.16062077 |
| 94 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15653002 |
| 95 | negative regulation of interleukin-17 production (GO:0032700) | 3.15540236 |
| 96 | phagocytosis, engulfment (GO:0006911) | 3.15237481 |
| 97 | regulation of tolerance induction (GO:0002643) | 3.14345109 |
| 98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13988762 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13912417 |
| 100 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.13589422 |
| 101 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13530511 |
| 102 | neutrophil migration (GO:1990266) | 3.12245956 |
| 103 | lipoxygenase pathway (GO:0019372) | 3.11830919 |
| 104 | regulation of monocyte chemotaxis (GO:0090025) | 3.11787973 |
| 105 | amino sugar catabolic process (GO:0046348) | 3.11389379 |
| 106 | positive regulation of lymphocyte migration (GO:2000403) | 3.09353308 |
| 107 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05889091 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04520519 |
| 109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.03706932 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 3.03564949 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.02219911 |
| 112 | granulocyte chemotaxis (GO:0071621) | 3.01130875 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00577163 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.99173376 |
| 115 | natural killer cell mediated immunity (GO:0002228) | 2.96933696 |
| 116 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96933696 |
| 117 | response to protozoan (GO:0001562) | 2.96826104 |
| 118 | leukocyte degranulation (GO:0043299) | 2.96591849 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.95950664 |
| 120 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.94321363 |
| 121 | regulation of hypersensitivity (GO:0002883) | 2.92149639 |
| 122 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91487726 |
| 123 | T-helper 1 type immune response (GO:0042088) | 2.91437402 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 2.91414827 |
| 125 | glycosphingolipid catabolic process (GO:0046479) | 2.91126650 |
| 126 | dendritic cell differentiation (GO:0097028) | 2.90711327 |
| 127 | granulocyte migration (GO:0097530) | 2.90660077 |
| 128 | cellular response to interferon-beta (GO:0035458) | 2.90513451 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89849366 |
| 130 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89069675 |
| 131 | regulation of regulated secretory pathway (GO:1903305) | 2.87404348 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87187402 |
| 133 | negative regulation of interleukin-6 production (GO:0032715) | 2.76139205 |
| 134 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76138772 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.75735248 |
| 136 | regulation of interleukin-12 production (GO:0032655) | 2.72979760 |
| 137 | cellular response to interferon-gamma (GO:0071346) | 2.72455929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.43556596 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.37434594 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.31203376 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.87899254 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.55362133 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.02546304 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84198631 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.74782853 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.73751928 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.40154810 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.13115471 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96960851 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.95962384 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86168284 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.77796032 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71383480 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57073392 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.56120749 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.56068607 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.49895512 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48594323 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19916356 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.07237609 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05536364 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98391987 |
| 26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.93291171 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91213935 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85299025 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84534632 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80911880 |
| 31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80142793 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78046124 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75165602 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73739902 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.73500269 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71122660 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69897861 |
| 38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69822566 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66751112 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65901256 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63864652 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62973886 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.60937028 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57005008 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55565805 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55547978 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54946613 |
| 48 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53579045 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51976938 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49852998 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49637058 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.49155453 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46637690 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42213856 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39362342 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36315674 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34487927 |
| 58 | MYB_26560356_Chip-Seq_TH1_Human | 1.32812250 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31629830 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31214554 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19461756 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19279804 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18273818 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17439738 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12799443 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11444960 |
| 67 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11440710 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11122444 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08512903 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08067850 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07833973 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06438395 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01238000 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00596267 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97531373 |
| 76 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97101937 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96462789 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94115946 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93715941 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91865894 |
| 81 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90390731 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86685678 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86539753 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86251887 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86162719 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86032083 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85951929 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85848399 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83689998 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83362885 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82047111 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79052326 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78403496 |
| 94 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.78062584 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77988812 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77556696 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74819592 |
| 98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74605595 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73810504 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 0.72184850 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71015114 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69083398 |
| 103 | GATA1_22025678_ChIP-Seq_K562_Human | 0.67938895 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67077091 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65894467 |
| 106 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.65666755 |
| 107 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.65016777 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.64081726 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62348586 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61341985 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61341985 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61264150 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60687840 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59569484 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59490143 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58574279 |
| 117 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56283956 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.56178435 |
| 119 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.55205035 |
| 120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54935334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.94981665 |
| 2 | * MP0003436_decreased_susceptibility_to | 4.03963744 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 3.79435120 |
| 4 | * MP0002419_abnormal_innate_immunity | 3.57461245 |
| 5 | MP0009785_altered_susceptibility_to | 3.57092665 |
| 6 | MP0003303_peritoneal_inflammation | 3.48017029 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.44503960 |
| 8 | MP0006082_CNS_inflammation | 3.38049556 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.28507844 |
| 10 | * MP0005025_abnormal_response_to | 3.04602649 |
| 11 | MP0003724_increased_susceptibility_to | 2.79600516 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.74708531 |
| 13 | MP0005387_immune_system_phenotype | 2.63787673 |
| 14 | MP0001790_abnormal_immune_system | 2.63787673 |
| 15 | MP0005671_abnormal_response_to | 2.57869209 |
| 16 | * MP0002723_abnormal_immune_serum | 2.54113367 |
| 17 | MP0001800_abnormal_humoral_immune | 2.49566851 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.42600321 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.38033009 |
| 20 | * MP0001819_abnormal_immune_cell | 2.34084578 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.32195658 |
| 22 | MP0000685_abnormal_immune_system | 2.31205408 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.16977728 |
| 24 | MP0004510_myositis | 2.13432088 |
| 25 | * MP0001533_abnormal_skeleton_physiology | 2.13015534 |
| 26 | MP0001853_heart_inflammation | 2.12007777 |
| 27 | MP0002405_respiratory_system_inflammati | 2.09448674 |
| 28 | MP0000343_altered_response_to | 2.08739571 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.99281224 |
| 30 | MP0003075_altered_response_to | 1.94970034 |
| 31 | MP0009840_abnormal_foam_cell | 1.88541827 |
| 32 | MP0009764_decreased_sensitivity_to | 1.86126225 |
| 33 | MP0008469_abnormal_protein_level | 1.73266041 |
| 34 | MP0003448_altered_tumor_morphology | 1.68668520 |
| 35 | MP0005310_abnormal_salivary_gland | 1.67596653 |
| 36 | * MP0000716_abnormal_immune_system | 1.63366099 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.60196107 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.57844825 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.56201851 |
| 40 | MP0003690_abnormal_glial_cell | 1.55850378 |
| 41 | MP0002006_tumorigenesis | 1.55072459 |
| 42 | MP0004947_skin_inflammation | 1.50642490 |
| 43 | MP0000858_altered_metastatic_potential | 1.48896756 |
| 44 | MP0005166_decreased_susceptibility_to | 1.47617569 |
| 45 | * MP0002398_abnormal_bone_marrow | 1.46699967 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.43906503 |
| 47 | * MP0002998_abnormal_bone_remodeling | 1.39095745 |
| 48 | MP0009278_abnormal_bone_marrow | 1.38688710 |
| 49 | MP0006054_spinal_hemorrhage | 1.35672320 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.33427091 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.32566141 |
| 52 | * MP0002429_abnormal_blood_cell | 1.31818643 |
| 53 | MP0008004_abnormal_stomach_pH | 1.31316943 |
| 54 | MP0000604_amyloidosis | 1.29951815 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.29887390 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.28991548 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.27768980 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.24758167 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.22573151 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.20705790 |
| 61 | MP0002722_abnormal_immune_system | 1.19239424 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.18511379 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.18511379 |
| 64 | MP0005164_abnormal_response_to | 1.14988417 |
| 65 | MP0003828_pulmonary_edema | 1.13662641 |
| 66 | MP0001851_eye_inflammation | 1.11336178 |
| 67 | MP0003186_abnormal_redox_activity | 1.10644018 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.02711726 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.00056430 |
| 70 | MP0009763_increased_sensitivity_to | 0.98068709 |
| 71 | MP0002933_joint_inflammation | 0.95956528 |
| 72 | * MP0005390_skeleton_phenotype | 0.95796787 |
| 73 | MP0004883_abnormal_blood_vessel | 0.95736518 |
| 74 | MP0002254_reproductive_system_inflammat | 0.95362783 |
| 75 | MP0010307_abnormal_tumor_latency | 0.94084412 |
| 76 | MP0000249_abnormal_blood_vessel | 0.91113352 |
| 77 | MP0003329_amyloid_beta_deposits | 0.89532297 |
| 78 | MP0002132_abnormal_respiratory_system | 0.84357597 |
| 79 | MP0008260_abnormal_autophagy | 0.83613853 |
| 80 | MP0000490_abnormal_crypts_of | 0.81910285 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.78853373 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.74873926 |
| 83 | MP0002090_abnormal_vision | 0.74733133 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.74045292 |
| 85 | MP0000371_diluted_coat_color | 0.72725098 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.72408034 |
| 87 | * MP0003795_abnormal_bone_structure | 0.70710271 |
| 88 | MP0001542_abnormal_bone_strength | 0.68865485 |
| 89 | MP0001663_abnormal_digestive_system | 0.68316846 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.67886415 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.66470426 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.65744330 |
| 93 | MP0008874_decreased_physiological_sensi | 0.65160384 |
| 94 | MP0001873_stomach_inflammation | 0.64644045 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.64351866 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.63161112 |
| 97 | MP0003866_abnormal_defecation | 0.60773864 |
| 98 | * MP0000920_abnormal_myelination | 0.60341108 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.60292163 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.58148283 |
| 101 | MP0005365_abnormal_bile_salt | 0.58077827 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.56259829 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.56218722 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.56158194 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.53302968 |
| 106 | MP0003091_abnormal_cell_migration | 0.51744180 |
| 107 | MP0005165_increased_susceptibility_to | 0.51046298 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.50556313 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.50427442 |
| 110 | MP0003879_abnormal_hair_cell | 0.49973168 |
| 111 | MP0003195_calcinosis | 0.49300297 |
| 112 | MP0004381_abnormal_hair_follicle | 0.49119126 |
| 113 | MP0004858_abnormal_nervous_system | 0.48899882 |
| 114 | * MP0008873_increased_physiological_sensi | 0.48290030 |
| 115 | MP0000609_abnormal_liver_physiology | 0.47676579 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47482830 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.47227374 |
| 118 | MP0005451_abnormal_body_composition | 0.47109126 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.43991820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.45656464 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.93948367 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.72297983 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.99472264 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.67758131 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.57604940 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.11406322 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 5.10846617 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.83994241 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.74358859 |
| 11 | Recurrent skin infections (HP:0001581) | 4.67632669 |
| 12 | Obstructive lung disease (HP:0006536) | 4.61472202 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.61472202 |
| 14 | Gingivitis (HP:0000230) | 4.53518152 |
| 15 | Myositis (HP:0100614) | 4.04934843 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04442506 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04442506 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04442506 |
| 19 | Glomerulonephritis (HP:0000099) | 4.04272745 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99567824 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.97318550 |
| 22 | Orchitis (HP:0100796) | 3.58389887 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.57844231 |
| 24 | Stomatitis (HP:0010280) | 3.56491419 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.55771004 |
| 26 | Optic neuritis (HP:0100653) | 3.33417332 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.33417332 |
| 28 | Cellulitis (HP:0100658) | 3.26718620 |
| 29 | Mutism (HP:0002300) | 3.25486075 |
| 30 | Amyloidosis (HP:0011034) | 3.08360515 |
| 31 | Urticaria (HP:0001025) | 3.08254432 |
| 32 | Pustule (HP:0200039) | 3.04834098 |
| 33 | Meningitis (HP:0001287) | 3.01485722 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01230561 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01230561 |
| 36 | Vasculitis (HP:0002633) | 3.00394089 |
| 37 | Periodontitis (HP:0000704) | 2.98325539 |
| 38 | Encephalitis (HP:0002383) | 2.97172953 |
| 39 | Recurrent viral infections (HP:0004429) | 2.95319698 |
| 40 | Recurrent pneumonia (HP:0006532) | 2.93853809 |
| 41 | Prostate neoplasm (HP:0100787) | 2.92435673 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.91177930 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.90715778 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.81104829 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.77767040 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77767040 |
| 47 | Increased serum ferritin (HP:0003281) | 2.74970159 |
| 48 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74949641 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.68570424 |
| 50 | Petechiae (HP:0000967) | 2.67428892 |
| 51 | Thick nail (HP:0001805) | 2.67024883 |
| 52 | Osteomyelitis (HP:0002754) | 2.66067007 |
| 53 | Increased IgE level (HP:0003212) | 2.64950866 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.63271826 |
| 55 | Joint hemorrhage (HP:0005261) | 2.58747672 |
| 56 | Nephritis (HP:0000123) | 2.58161721 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56269487 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56269487 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56269487 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.56153797 |
| 61 | Abnormality of complement system (HP:0005339) | 2.54868073 |
| 62 | T lymphocytopenia (HP:0005403) | 2.52477412 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46139966 |
| 64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44885708 |
| 65 | Poor head control (HP:0002421) | 2.41864213 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.39737396 |
| 67 | Pulmonary embolism (HP:0002204) | 2.37270599 |
| 68 | Myocardial infarction (HP:0001658) | 2.36006825 |
| 69 | * Disinhibition (HP:0000734) | 2.35669346 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.35413868 |
| 71 | * Basal ganglia calcification (HP:0002135) | 2.35089687 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.35076973 |
| 73 | Chest pain (HP:0100749) | 2.33046036 |
| 74 | Leukocytosis (HP:0001974) | 2.29615879 |
| 75 | Hemoptysis (HP:0002105) | 2.27922325 |
| 76 | Complement deficiency (HP:0004431) | 2.27616491 |
| 77 | Anorexia (HP:0002039) | 2.26257908 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.25971166 |
| 79 | Nuclear cataract (HP:0100018) | 2.25246828 |
| 80 | Polyneuropathy (HP:0001271) | 2.24817770 |
| 81 | Gangrene (HP:0100758) | 2.24452378 |
| 82 | Episodic fever (HP:0001954) | 2.23629513 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.23429747 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.21779909 |
| 85 | Loss of speech (HP:0002371) | 2.20995413 |
| 86 | Hematochezia (HP:0002573) | 2.17963452 |
| 87 | Gingival bleeding (HP:0000225) | 2.11989683 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.11399145 |
| 89 | Arterial thrombosis (HP:0004420) | 2.10609368 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 2.10061577 |
| 91 | Diminished motivation (HP:0000745) | 2.09738677 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.08670170 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08670170 |
| 94 | Sepsis (HP:0100806) | 2.08117549 |
| 95 | Increased IgM level (HP:0003496) | 2.07179304 |
| 96 | Purpura (HP:0000979) | 2.06642001 |
| 97 | Progressive visual loss (HP:0000529) | 2.06424444 |
| 98 | Apathy (HP:0000741) | 2.05714278 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.02691745 |
| 100 | Malnutrition (HP:0004395) | 1.98977853 |
| 101 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98069747 |
| 102 | Epistaxis (HP:0000421) | 1.96929837 |
| 103 | * Axonal loss (HP:0003447) | 1.95956108 |
| 104 | Cerebral inclusion bodies (HP:0100314) | 1.95820191 |
| 105 | IgM deficiency (HP:0002850) | 1.95797729 |
| 106 | * Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95322867 |
| 107 | Chronic otitis media (HP:0000389) | 1.95135776 |
| 108 | Cheilitis (HP:0100825) | 1.93973938 |
| 109 | Inflammation of the large intestine (HP:0002037) | 1.93219017 |
| 110 | J-shaped sella turcica (HP:0002680) | 1.92735934 |
| 111 | Colitis (HP:0002583) | 1.92605817 |
| 112 | Tetraparesis (HP:0002273) | 1.92080611 |
| 113 | Glomerulopathy (HP:0100820) | 1.91872450 |
| 114 | Vertigo (HP:0002321) | 1.91397295 |
| 115 | Eosinophilia (HP:0001880) | 1.88879448 |
| 116 | Skin ulcer (HP:0200042) | 1.88593629 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87845535 |
| 118 | Acne (HP:0001061) | 1.87594856 |
| 119 | Restrictive lung disease (HP:0002091) | 1.87099209 |
| 120 | Hypochromic anemia (HP:0001931) | 1.86407977 |
| 121 | Thoracic kyphosis (HP:0002942) | 1.84272486 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.83177545 |
| 123 | Albinism (HP:0001022) | 1.81551135 |
| 124 | Abnormality of the pleura (HP:0002103) | 1.79532162 |
| 125 | Abnormality of the lumbar spine (HP:0100712) | 1.78459466 |
| 126 | Gastrointestinal inflammation (HP:0004386) | 1.76489475 |
| 127 | Premature loss of primary teeth (HP:0006323) | 1.75985457 |
| 128 | Thrombocytosis (HP:0001894) | 1.74764536 |
| 129 | * Bone pain (HP:0002653) | 1.73647723 |
| 130 | Nausea (HP:0002018) | 1.72301665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.94474913 |
| 2 | RIPK4 | 4.73530436 |
| 3 | IRAK4 | 3.91929649 |
| 4 | MAP3K14 | 3.64294479 |
| 5 | TBK1 | 2.97905177 |
| 6 | IRAK3 | 2.93916148 |
| 7 | TYK2 | 2.91459428 |
| 8 | PBK | 2.71146392 |
| 9 | MAP4K1 | 2.57225889 |
| 10 | KIT | 2.30978908 |
| 11 | IKBKB | 2.13744951 |
| 12 | TAOK1 | 2.10867629 |
| 13 | TGFBR2 | 2.06314344 |
| 14 | TXK | 2.03575283 |
| 15 | IKBKE | 1.94084886 |
| 16 | PIM2 | 1.92394317 |
| 17 | PRPF4B | 1.90947149 |
| 18 | ERN1 | 1.87507174 |
| 19 | TNK2 | 1.83930871 |
| 20 | TAOK2 | 1.76647097 |
| 21 | CSK | 1.68332906 |
| 22 | CSF1R | 1.66087499 |
| 23 | JAK1 | 1.65385234 |
| 24 | BTK | 1.65124654 |
| 25 | JAK3 | 1.61348601 |
| 26 | TEC | 1.60740793 |
| 27 | NME2 | 1.54163178 |
| 28 | HCK | 1.50316788 |
| 29 | LYN | 1.50188693 |
| 30 | ZAP70 | 1.48039448 |
| 31 | CLK1 | 1.41057970 |
| 32 | FES | 1.36924381 |
| 33 | ABL2 | 1.33728199 |
| 34 | TAOK3 | 1.32029523 |
| 35 | GRK7 | 1.31918360 |
| 36 | NEK9 | 1.28502250 |
| 37 | PIM1 | 1.21236778 |
| 38 | SIK3 | 1.19660195 |
| 39 | TESK2 | 1.18654274 |
| 40 | MATK | 1.18423737 |
| 41 | * SYK | 1.17820741 |
| 42 | MAP2K3 | 1.15393537 |
| 43 | STK10 | 1.09492494 |
| 44 | MST4 | 1.09051974 |
| 45 | EPHB1 | 1.05044160 |
| 46 | JAK2 | 1.04539878 |
| 47 | CDC42BPA | 1.03712172 |
| 48 | CHUK | 1.03403523 |
| 49 | YES1 | 1.02432706 |
| 50 | FGR | 1.01303378 |
| 51 | RPS6KA4 | 0.99858990 |
| 52 | BMPR2 | 0.98360179 |
| 53 | TRPM7 | 0.98170653 |
| 54 | MAP3K10 | 0.97808336 |
| 55 | * LCK | 0.96544549 |
| 56 | ITK | 0.95520997 |
| 57 | DDR2 | 0.91834458 |
| 58 | ARAF | 0.90836263 |
| 59 | MAP3K13 | 0.90372355 |
| 60 | STK4 | 0.88753205 |
| 61 | MST1R | 0.88721769 |
| 62 | BMX | 0.83611789 |
| 63 | PRKCD | 0.80883159 |
| 64 | ADRBK2 | 0.77739707 |
| 65 | EIF2AK2 | 0.77690437 |
| 66 | MARK2 | 0.75254989 |
| 67 | MARK3 | 0.71974454 |
| 68 | BMPR1B | 0.70161498 |
| 69 | MAP2K6 | 0.69256156 |
| 70 | KSR2 | 0.66116200 |
| 71 | ABL1 | 0.65593195 |
| 72 | LRRK2 | 0.65572559 |
| 73 | RIPK1 | 0.62907814 |
| 74 | MAP3K12 | 0.61412417 |
| 75 | ERBB3 | 0.61001580 |
| 76 | EGFR | 0.59625576 |
| 77 | MAPK12 | 0.59212126 |
| 78 | IRAK2 | 0.58956674 |
| 79 | SCYL2 | 0.58951217 |
| 80 | PRKD2 | 0.58634939 |
| 81 | MAP3K11 | 0.58408574 |
| 82 | MAP3K3 | 0.56707565 |
| 83 | CAMKK2 | 0.54913621 |
| 84 | PAK4 | 0.53934445 |
| 85 | MAPK7 | 0.53495724 |
| 86 | MOS | 0.51013795 |
| 87 | DAPK2 | 0.48949587 |
| 88 | RPS6KA6 | 0.48811655 |
| 89 | CAMK1D | 0.46323569 |
| 90 | IRAK1 | 0.45400154 |
| 91 | ACVR1B | 0.45034590 |
| 92 | TRIB3 | 0.44507661 |
| 93 | GRK6 | 0.44216865 |
| 94 | MAPKAPK2 | 0.44017830 |
| 95 | PIK3CG | 0.41392387 |
| 96 | SIK1 | 0.40965650 |
| 97 | MAP3K5 | 0.40594375 |
| 98 | MAP3K6 | 0.39993903 |
| 99 | CDK19 | 0.39888220 |
| 100 | EIF2AK3 | 0.39510853 |
| 101 | PTK6 | 0.39181779 |
| 102 | DYRK1B | 0.39170756 |
| 103 | TESK1 | 0.37236383 |
| 104 | RPS6KC1 | 0.37001061 |
| 105 | RPS6KL1 | 0.37001061 |
| 106 | FYN | 0.36444752 |
| 107 | PRKCQ | 0.36071816 |
| 108 | CDK6 | 0.35704308 |
| 109 | CAMKK1 | 0.34573942 |
| 110 | FGFR3 | 0.33856818 |
| 111 | HIPK2 | 0.33410350 |
| 112 | PDK1 | 0.32316301 |
| 113 | PRKG2 | 0.32234753 |
| 114 | EPHA3 | 0.30966695 |
| 115 | SIK2 | 0.30542443 |
| 116 | IGF1R | 0.28912541 |
| 117 | PDPK1 | 0.28830223 |
| 118 | MAP3K1 | 0.28207654 |
| 119 | MAPK4 | 0.26526979 |
| 120 | MAP3K8 | 0.25648675 |
| 121 | FLT3 | 0.25417622 |
| 122 | STK3 | 0.24775167 |
| 123 | PKN2 | 0.23321685 |
| 124 | KDR | 0.22302418 |
| 125 | RPS6KA2 | 0.21132816 |
| 126 | TTN | 0.20912147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.92726752 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.56901424 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80971763 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.77598584 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.70087476 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.53938938 |
| 7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52013700 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.51472425 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.49904929 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45066060 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.36125105 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.29400549 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24863892 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.23148212 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.21060955 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16732886 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11911340 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.10641188 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 2.08631560 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91305377 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.84548050 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.80953409 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73573636 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73337402 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64314398 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59834573 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.49809748 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48496027 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48210079 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47593004 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45644998 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45579469 |
| 33 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44024893 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43488125 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40503424 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37170568 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.32565693 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.28882334 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23569275 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19227447 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18217255 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12276222 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10791330 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09539330 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09521382 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07512946 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03317294 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99842668 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99617229 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98464955 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92650100 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.91051479 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86557762 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84296000 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83140873 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81944594 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.80438428 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.75181789 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.71254755 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.70510738 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68727502 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64499497 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61560958 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61168237 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59293941 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59086604 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55464088 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.53385830 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52848940 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52010558 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51230707 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49661988 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48417762 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48116879 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44451051 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44177396 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42821033 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42577054 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42086045 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.41340830 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40602019 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38826429 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38008028 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37695482 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34982561 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33644393 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.33194550 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32714669 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30413910 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29979719 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28324368 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28126180 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26417152 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24004889 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24002044 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23402984 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21675640 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21573753 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.21261017 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21105024 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20948578 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20192622 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19497618 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14290420 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14074749 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11771869 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11065808 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10621423 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.10424652 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10353857 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07802412 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06708314 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06661534 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.06415350 |

